Home›People›Jonathan Piccini
Jonathan Piccini

Jonathan Piccini

Professor of medicine and population health at Duke University; on the SymKardia team

Executive
Updated Nov 6, 2026·Latest SEC filing Oct 28, 2026·Suggest an edit

About Jonathan Piccini

Jonathan Piccini is a clinical cardiac electrophysiologist and a professor of medicine and population health at Duke University. He directs the cardiac electrophysiology section at the Duke Heart Center. He is also a member of the Duke Clinical Research Institute. Duke names him the Ursula Geller Distinguished Professor of Research in Cardiovascular Diseases. His clinical focus is atrial fibrillation and complex arrhythmias, especially catheter ablation, pacing and lead extraction. He is on the team at SymKardia, which aims to treat arrhythmias with selective cardiac neuromodulation.

He sits on the Heart Rhythm Society's Board of Trustees. He is an associate editor at JACC: Clinical Electrophysiology and an elected member of the American Society for Clinical Investigation. He has more than 600 publications in heart rhythm medicine.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Jonathan Piccini in the role, so the role may have started earlier or lasted longer.

Duke University Current
Professor of Medicine and Population Health
Duke Heart Center Current
Director of the Cardiac Electrophysiology section
Duke Clinical Research Institute Current
Member
JACC: Clinical Electrophysiology Current
Associate Editor
Heart Rhythm Society Current
Board of Trustees
SymKardia, Inc.
Executive officer
2026 · Westlake, OH
SymKardia is developing selective cardiac neuromodulation as a new way to treat patients with cardiac arrhythmias.

Key Colleagues at Startups

The people Jonathan Piccini works with at each company, as listed on that company's latest Form D.

SymKardia, Inc. · Form D/A, Oct 28, 2026
AC
Anthony Caparso
President and director
Bruce KenKnight
Bruce KenKnight
Chief Executive Officer
Steven Girouard
Steven Girouard
Executive officer
Imad Libbus
Imad Libbus
Chief Scientific Officer
Dwight Skinner
Dwight Skinner
Executive officer
RP
AS
Arun Sridhar
Director
CR
JB

Sources

  1. SECSymKardia, Inc. Form D/A, filed Oct 28, 2026